4.5 Article

Real life evaluation of safinamide effectiveness in Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide

Fabrizio Stocchi et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Article Pharmacology & Pharmacy

Safinamide: First Global Approval

Emma D. Deeks

Article Clinical Neurology

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease

Denes Zadori et al.

JOURNAL OF NEURAL TRANSMISSION (2013)

Review Chemistry, Medicinal

Lights and Shadows on Monoamine Oxidase Inhibition in Neuroprotective Pharmacological Therapies

Claudia Binda et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)

Review Clinical Neurology

Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease

Claire L. Tomlinson et al.

MOVEMENT DISORDERS (2010)

Editorial Material Pharmacology & Pharmacy

An expert opinion on safinamide in Parkinson's disease

Marco Onofrj et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)

Article Clinical Neurology

The Unified Dyskinesia Rating Scale: Presentation and Clinimetric Profile

Christopher G. Goetz et al.

MOVEMENT DISORDERS (2008)

Article Clinical Neurology

Safinamide - From molecular targets to a new anti-Parkinson drug

C. Caccia et al.

NEUROLOGY (2006)

Article Pharmacology & Pharmacy

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

MBH Youdim et al.

BRITISH JOURNAL OF PHARMACOLOGY (2001)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY